After pricing its IPO below the expected range, CoreWeave’s stock didn’t do much in its debut on Friday, reflecting concerns about the macro environment.
Related Posts
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Amazon’s cloud unit forms agentic AI group
Swami Sivasubramanian, who has run Amazon Web Services’ database business, will lead a new group focused on agentic AI.
GM, Ford report best annual U.S. sales since 2019
Both General Motors and Ford Motor on Friday reported their best annual U.S. new vehicle sales since 2019.